Which Is a Better Investment, Acadia Healthcare Company Inc or Davita Inc Stock?

By Cynthia McLaughlin
October 12, 2026
Large versus logo comparing two stocks in the same industry
Featured Tickers:

Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Acadia Healthcare Company, Inc. or DaVita Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Acadia Healthcare Company, Inc. and DaVita Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Acadia Healthcare Company, Inc. and DaVita Inc.

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Latest Health Care Providers & Services and Acadia Healthcare Company, Inc., DaVita Inc. Stock News

As of October 9, 2026, Acadia Healthcare Company, Inc. had a $2.7 billion market capitalization, compared to the Health Care Providers & Services median of $1.6 million. Acadia Healthcare Company, Inc.’s stock is up 108.5% in 2026, up 2.5% in the previous five trading days and up 14.26% in the past year.

Currently, Acadia Healthcare Company, Inc. does not have a price-earnings ratio. Acadia Healthcare Company, Inc.’s trailing 12-month revenue is $3.4 billion with a -33.4% net profit margin. Year-over-year quarterly sales growth most recently was -0.4%. Analysts expect adjusted earnings to reach $1.553 per share for the current fiscal year. Acadia Healthcare Company, Inc. does not currently pay a dividend.

As of October 9, 2026, DaVita Inc. had a $11.4 billion market cap, putting it in the 80th percentile of all stocks. DaVita Inc.’s stock is up 60.3% in 2026, up 1.9% in the previous five trading days and up 40.16% in the past year.

Currently, DaVita Inc.’s price-earnings ratio is 15.3. DaVita Inc.’s trailing 12-month revenue is $14.0 billion with a 6.0% net profit margin. Year-over-year quarterly sales growth most recently was 5.2%. Analysts expect adjusted earnings to reach $14.825 per share for the current fiscal year. DaVita Inc. does not currently pay a dividend.

How We Compare Acadia Healthcare Company, Inc. and DaVita Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Acadia Healthcare Company, Inc. and DaVita Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Acadia Healthcare Company, Inc. and DaVita Inc. Growth Grades

Company Ticker Growth
Acadia Healthcare Company, Inc. ACHC A
DaVita Inc. DVA B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Acadia Healthcare Company, Inc. has a Growth Score of 100, which is Very Strong. DaVita Inc. has a Growth Score of 73, which is Strong.

The Growth Grade Winner: Acadia Healthcare Company, Inc.

As you can clearly see from the Growth Grade breakdown above, Acadia Healthcare Company, Inc. has a more attractive growth grade than DaVita Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Acadia Healthcare Company, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Acadia Healthcare Company, Inc. and DaVita Inc.’s Quality Grades

Company Ticker Quality
Acadia Healthcare Company, Inc. ACHC C
DaVita Inc. DVA A

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Acadia Healthcare Company, Inc. has a Quality Score of 48, which is Average. DaVita Inc. has a Quality Score of 85, which is Very Strong.

The Quality Grade Winner: DaVita Inc.

As you can clearly see from the Quality Grade breakdown above, DaVita Inc. has a better overall quality grade than Acadia Healthcare Company, Inc.. For investors who are looking for companies with higher quality than others in the same industry, DaVita Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Acadia Healthcare Company, Inc. and DaVita Inc.’s Estimate Revisions Grades

Company Ticker Earnings Estimate
Acadia Healthcare Company, Inc. ACHC B
DaVita Inc. DVA C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Acadia Healthcare Company, Inc. has a Earnings Estimate Score of 69, which is Positive. DaVita Inc. has a Earnings Estimate Score of 48, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Acadia Healthcare Company, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Acadia Healthcare Company, Inc. has a better Earnings Estimate Revisions Grade than DaVita Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Acadia Healthcare Company, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions

Other Acadia Healthcare Company, Inc. and DaVita Inc. Grades

In addition to Growth, Quality and Estimate Revisions, A+ Investor also provides grades for Value and Momentum.

AAII Platinum Banner

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Acadia Healthcare Company, Inc. and DaVita Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Acadia Healthcare Company, Inc. or DaVita Inc. Stock?

Overall, Acadia Healthcare Company, Inc. stock has a Growth Score of 100, Estimate Revisions Score of 69 and Quality Score of 48.

DaVita Inc. stock has a Growth Score of 73, Estimate Revisions Score of 48 and Quality Score of 85.

Comparing Acadia Healthcare Company, Inc. and DaVita Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

Learn More About A+ Investor

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.



Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.